文献速递免疫规划卫生政策与健康促进传染病防控与疫情报告

突破性COVID-19感染与感知疫苗有效性

Breakthrough COVID-19 infections and perceived vaccine effectiveness.
PubMed 文献 · Vaccine · 2023-11-22

2023年2月27日至3月9日对美国2500名成年人进行配额抽样调查,分析1928名接种COVID-19疫苗者的应答,发现突破性感染经历与较低的感知疫苗有效性相关,即使控制人口学和政治因素后仍相关。

要点

  • 接种后检测阳性者中21.18%认为疫苗「不如最初预期有效」,无突破性感染者中为10.0%(X2=75.551;φ=0.198;p≤0.001)。
  • 自身经历突破性感染者报告感知疫苗有效性的可能性低1.37倍,家人经历突破性感染者低1.64倍。
  • 同时经历个人和家庭突破性感染者最不可能将疫苗描述为「非常有效」,可能性低近两倍。

核心结论

  • 突破性感染与较低的总体感知疫苗有效性相关,即使考虑人口学和政治因素后仍如此。

研究设计与样本

  • 2023年2月27日至3月9日对美国2500名成年人进行调查,采用分层配额抽样以确保代表性,分析1928名接种COVID-19疫苗者的应答。

主要发现

  • 接种后COVID-19检测阳性者中21.18%认为疫苗「不如最初预期有效」,无突破性感染者中为10.0%(X2=75.551;φ=0.198;p≤0.001)。
  • 自身经历突破性感染者报告感知疫苗有效性的可能性低1.37倍,家人经历突破性感染者低1.64倍,其他条件不变。
  • 同时经历个人和家庭突破性感染者效应最大,该组将COVID-19疫苗描述为「非常有效」的可能性低近两倍。

临床怎么用

  • 原文建议公共官员和卫生专业人员应主动工作,确保突破性感染在总体疫苗有效性的更广泛背景下被理解。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: While SARS-CoV-2 vaccines provide significant protection against severe COVID-19 illness, breakthrough infections have sparked confusion among patients about the effectiveness of vaccination. It's unclear if (or to what extent) breakthrough infection experiences impact public perceptions of COVID-vaccine effectiveness, though the answer may have significant implications for public health communications and ongoing vaccine acceptance. METHODS: We conducted a survey of 2,500 adults in the United States (February 27 - March 9, 2023) in order to better understand the relationship between breakthrough COVID-19 infections and perceived vaccine effectiveness. Survey respondents were selected using a stratified, quota sampling approach to ensure representativeness; analysis was conducted on responses from 1,928 participants who received a COVID-19 vaccine. FINDINGS: Among those who tested positive for COVID-19 after being vaccinated, 21.18 % said that COVID-19 vaccines had been "less effective" than they initially expected, compared with 10.0 % of those who did not experience any breakthrough infections (X2 = 75.551; φ = 0.198; p ≤ 0.001). Those who experienced their own breakthrough infection were 1.37 times less likely to report perceived vaccine efficacy, while those whose family members experienced a breakthrough infection were 1.64 times less likely to report the same, ceteris paribus. The largest effect was observed among those who experienced both a personal and familial breakthrough infection. This group was almost two times less likely to describe COVID-19 vaccines as "very effective". DISCUSSION: Breakthrough infections correlated with lower overall levels of perceived vaccine effectiveness, even after accounting for demographic and political considerations. Moving forward, public officials and health professionals should work proactively to ensure that breakthrough infections are understood in the broader context of overall vaccine effectiveness.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Neely SR, Hao F. Breakthrough COVID-19 infections and perceived vaccine effectiveness. Vaccine. 2023. PMID: 37996290. doi:10.1016/j.vaccine.2023.11.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。